文献速递复苏、休克与脓毒症创伤与烧伤

人工氧载体与红细胞替代品:面向军事与临床相关性的历史回顾与近期进展

Artificial oxygen carriers and red blood cell substitutes: A historic overview and recent developments toward military and clinical relevance.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论系统综述汇总无细胞与封装血红蛋白氧载体、全氟化碳乳剂、天然血红蛋白替代品等人工氧载体,讨论其发展状态及临床与军事相关性。

本文为系统综述,针对库存红细胞在供应、免疫原性与病原污染方面的局限,以及战场等偏远严苛环境下血液制品易腐败的问题,回顾人工氧载体领域的重要技术。文章涵盖无细胞血红蛋白氧载体、封装血红蛋白氧载体、全氟化碳乳剂、天然血红蛋白替代品及其他新技术,讨论其发展状态、临床与军事相关性。原文未报告具体研究数据或推荐意见。

要点

  • 库存红细胞是失血性休克复苏的关键成分,但受供应、免疫原性与病原污染问题限制。
  • 在偏远或严苛环境(如战场)部署时,血液制品固有的易腐败性进一步构成障碍。
  • 为应对同种异体红细胞显著局限及对更好复苏疗法的迫切需求,已有大量研究投入开发安全、有效且可野外部署的人工氧载体。
  • 综述涵盖无细胞血红蛋白氧载体、封装血红蛋白氧载体、全氟化碳乳剂、天然血红蛋白替代品及其他新技术。
  • 文章讨论上述人工氧载体技术的发展状态及其临床与军事相关性。

研究设计与关键结果

  • 研究类型为系统综述,汇总人工氧载体领域最重要技术,包括无细胞与封装血红蛋白氧载体、全氟化碳乳剂、天然血红蛋白替代品及其他新技术。
  • 文章讨论上述技术的发展状态、临床与军事相关性,原文未报告具体效应量或临床终点数据。

证据类型、等级与局限

  • 证据类型:系统综述(原文标注证据等级为系统综述)。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Packed red blood cells are a critical component in the resuscitation of hemorrhagic shock. The availability of donor-derived blood products, however, suffers from issues of supply, immunogenicity, and pathogenic contamination. Deployment in remote or austere environments, such as the battlefield, is further hindered by the inherent perishability of blood products. To address the significant limitations of allogenic packed red blood cells and the urgent medical need for better resuscitative therapies for both combat casualties and civilians, there has been significant research invested in developing safe, effective, and field deployable artificial oxygen carriers. This article provides a comprehensive review of the most important technologies in the field of artificial oxygen carriers including cell-free and encapsulated hemoglobin-based oxygen carriers, perfluorocarbon emulsions, natural hemoglobin alternatives, as well as other novel technologies. Their development status, clinical, and military relevance are discussed. LEVEL OF EVIDENCE: Systematic review.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Bialas C, Moser C, Sims CA, et al. Artificial oxygen carriers and red blood cell substitutes: A historic overview and recent developments toward military and clinical relevance. J Trauma Acute Care Surg. 2019. PMID: 31246907. doi:10.1097/TA.0000000000002250

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。